0001628280-19-015069.txt : 20191213
0001628280-19-015069.hdr.sgml : 20191213
20191213160629
ACCESSION NUMBER: 0001628280-19-015069
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191213
FILED AS OF DATE: 20191213
DATE AS OF CHANGE: 20191213
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Buckley Sean D.
CENTRAL INDEX KEY: 0001744427
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-31564
FILM NUMBER: 191284665
MAIL ADDRESS:
STREET 1: C/O FIBROCELL SCIENCE, INC.
STREET 2: 405 EAGLEVIEW BOULEVARD
CITY: EXTON
STATE: PA
ZIP: 19341
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Fibrocell Science, Inc.
CENTRAL INDEX KEY: 0000357097
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 870458888
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 405 EAGLEVIEW BOULEVARD
CITY: EXTON
STATE: PA
ZIP: 19341
BUSINESS PHONE: 484-713-6000
MAIL ADDRESS:
STREET 1: 405 EAGLEVIEW BOULEVARD
CITY: EXTON
STATE: PA
ZIP: 19341
FORMER COMPANY:
FORMER CONFORMED NAME: ISOLAGEN INC
DATE OF NAME CHANGE: 20020320
FORMER COMPANY:
FORMER CONFORMED NAME: AMERICAN FINANCIAL HOLDING INC /DE
DATE OF NAME CHANGE: 19960330
FORMER COMPANY:
FORMER CONFORMED NAME: AMERICAN FINANCIAL HOLDING INC /CO
DATE OF NAME CHANGE: 19921008
4
1
wf-form4_157627117126415.xml
FORM 4
X0306
4
2019-12-13
1
0000357097
Fibrocell Science, Inc.
FCSC
0001744427
Buckley Sean D.
FIBROCELL SCIENCE, INC.
405 EAGLEVIEW BLVD
EXTON
PA
19341
0
1
0
0
Chief Financial Officer
Option to Purchase Common Stock
232.5
2019-12-13
4
D
0
200
D
2021-01-14
Common Stock
200.0
0
D
Option to Purchase Common Stock
82.35
2019-12-13
4
D
0
334
D
2023-07-19
Common Stock
334.0
0
D
Option to Purchase Common Stock
63.6
2019-12-13
4
D
0
1000
D
2025-04-01
Common Stock
1000.0
0
D
Option to Purchase Common Stock
11.25
2019-12-13
4
D
0
2229
D
2026-09-27
Common Stock
2229.0
0
D
Option to Purchase Common Stock
11.25
2019-12-13
4
D
0
4000
D
2027-03-16
Common Stock
4000.0
0
D
Option to Purchase Common Stock
3.45
2019-12-13
4
D
0
5000
D
2028-01-25
Common Stock
5000.0
0
D
Option to Purchase Common Stock
1.78
2019-12-13
4
D
0
30000
D
2029-04-12
Common Stock
30000.0
0
D
Option to Purchase Common Stock
1.82
2019-12-13
4
D
0
15000
D
2029-08-18
Common Stock
15000.0
0
D
Pursuant to the Merger Agreement, effective as of immediately prior to the effective time of the merger of the Company and Merger Sub, outstanding options, whether vested or not, became fully vested in accordance with the terms of the Merger Agreement and were canceled in exchange for a cash payment equal to the number of shares of Company common stock underlying the options multiplied by the excess of the per share merger consideration of $3.00 over the per share exercise price.
/s/ Sean D. Buckley
2019-12-13